Compositions produced using enteric pathogens and methods of use
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-039/112
C07K-014/255
C07K-014/205
A61K-039/02
A61K-039/00
출원번호
US-0798726
(2015-07-14)
등록번호
US-9463230
(2016-10-11)
발명자
/ 주소
Emery, Daryll A.
Straub, Darren E.
Wonderling, Laura
출원인 / 주소
EPITOPIX LLC
대리인 / 주소
Mueting, Raasch & Gebhardt, PA
인용정보
피인용 횟수 :
1인용 특허 :
54
초록▼
The present invention provides compositions including polypeptides having the characteristics of polypeptides expressed by a reference microbe such E. coli or Salmonella. Examples of Salmonella strains that can be used include, for instance, S. enterica serovar Newport, S. enterica serovar Enteritid
The present invention provides compositions including polypeptides having the characteristics of polypeptides expressed by a reference microbe such E. coli or Salmonella. Examples of Salmonella strains that can be used include, for instance, S. enterica serovar Newport, S. enterica serovar Enteritidis, S. enterica serovar Typhimurium, and S. enterica serovar Dublin. Also provided are compositions including polypeptides having a particular molecular weight and a mass fingerprint that includes polypeptide fragments having a particular set of masses, or polypeptides having an amino acid sequence with at least about 95% identity with an amino acid sequence, wherein the polypeptide has seroreactive activity. The present invention also provides methods of making and methods of using such compositions.
대표청구항▼
1. A method for decreasing intestinal colonization of an animal intestinally colonized by, or at risk of being intestinally colonized by a Salmonella spp., the method comprising parenterally administering an effective amount of a composition to the animal, wherein the composition comprises: a first
1. A method for decreasing intestinal colonization of an animal intestinally colonized by, or at risk of being intestinally colonized by a Salmonella spp., the method comprising parenterally administering an effective amount of a composition to the animal, wherein the composition comprises: a first isolated iron-regulated polypeptide from Salmonella enterica serovar Enteritidis having a molecular weight of about 92 kDa as measured following electrophoresis on an SDS-polyacrylamide gel, wherein the first isolated iron-regulated polypeptide, if digested with trypsin, produces polypeptide fragments having masses of 728.43 Da±300 parts per million (ppm), 815.38 Da±300 ppm, 888.41 Da±300 ppm, 957.50 Da±300 ppm, 972.50 Da±300 ppm, 986.54 Da±300 ppm, 998.45 Da±300 ppm, 1008.47 Da±300 ppm, 1047.53 Da±300 ppm, 1076.59 Da±300 ppm, 1113.56 Da±300 ppm, 1180.59 Da±300 ppm, 1219.61 Da±300 ppm, 1276.60 Da±300 ppm, 1282.74 Da±300 ppm, 1338.66 Da±300 ppm, 1384.65 Da±300 ppm, 1401.71 Da±300 ppm, 1402.67 Da±300 ppm, 1470.69 Da±300 ppm, 1519.80 Da±300 ppm, 1527.72 Da±300 ppm, 1648.75 Da±300 ppm, 1691.87 Da±300 ppm, 1712.86 Da±300 ppm, 1732.81 Da±300 ppm, 1758.82 Da±300 ppm, 1786.87 Da±300 ppm, 1894.97 Da±300 ppm, 1953.86 Da±300 ppm, 2159.05 Da±300 ppm, 2254.95 Da±300 ppm, 2284.27 Da±300 ppm, 2793.46 Da±300 ppm, and 2881.34 Da±300 ppm;a second isolated iron-regulated polypeptide from Salmonella enterica serovar Enteritidis having a molecular weight of about 91 kDa as measured following electrophoresis on an SDS-polyacrylamide gel, wherein the second isolated iron-regulated polypeptide, if digested with trypsin, produces polypeptide fragments having masses of 904.51 Da±300 ppm, 924.43 Da±300 ppm, 945.53 Da±300 ppm, 1004.49 Da±300 ppm, 1050.50 Da±300 ppm, 1075.60 Da±300 ppm, 1109.55 Da±300 ppm, 1199.63 Da±300 ppm, 1276.56 Da±300 ppm, 1294.58 Da±300 ppm, 1307.68 Da±300 ppm, 1343.65 Da±300 ppm, 1375.72 Da±300 ppm, 1417.75 Da±300 ppm, 1450.68 Da±300 ppm, 1509.63 Da±300 ppm, 1510.72 Da±300 ppm, 1601.89 Da±300 ppm, 1618.81 Da±300 ppm, 1624.79 Da±300 ppm, 1668.72 Da±300 ppm, 1766.91 Da±300 ppm, 1792.85 Da±300 ppm, 1808.87 Da±300 ppm, 1832.89 Da±300 ppm, 2013.02 Da±300 ppm, 2088.13 Da±300 ppm, 2269.01 Da±300 ppm, 2298.03 Da±300 ppm, 2453.09 Da±300 ppm, 2554.16 Da±300 ppm, and 2572.20 Da±300 ppm;a third isolated iron-regulated polypeptide from Salmonella enterica serovar Enteritidis having a molecular weight of about 86 kDa as measured following electrophoresis on an SDS-polyacrylamide gel, wherein the third isolated iron-regulated polypeptide, if digested with trypsin, produces polypeptide fragments having masses of 643.37 Da±300 ppm, 872.46 Da±300 ppm, 950.49 Da±300 ppm, 990.55 Da±300 ppm, 1082.61 Da±300 ppm, 1084.57 Da±300 ppm, 1095.49 Da±300 ppm, 1151.68 Da±300 ppm, 1181.55 Da±300 ppm, 1207.58 Da±300 ppm, 1324.75 Da±300 ppm, 1365.74 Da±300 ppm, 1377.66 Da±300 ppm, 1411.78 Da±300 ppm, 1432.77 Da±300 ppm, 1436.74 Da±300 ppm, 1499.71 Da±300 ppm, 1560.86 Da±300 ppm, 1584.74 Da±300 ppm, 1618.77 Da±300 ppm, 1633.84 Da±300 ppm, 1727.83 Da±300 ppm, 1870.95 Da±300 ppm, 1903.94 Da±300 ppm, 1974.95 Da±300 ppm, 1980.96 Da±300 ppm, 1997.06 Da±300 ppm, 2078.00 Da±300 ppm, 2192.94 Da±300 ppm, 2233.14 Da±300 ppm, 2371.13 Da±300 ppm, 2531.24 Da±300 ppm, 2622.42 Da±300 ppm, 2632.20 Da±300 ppm, 3098.47 Da±300 ppm, 3211.45 Da±300 ppm, and 3473.51 Da±300 ppm;a fourth isolated iron-regulated polypeptide from Salmonella enterica serovar Enteritidis having a molecular weight of about 83 kDa as measured following electrophoresis on an SDS-polyacrylamide gel, wherein the fourth isolated iron-regulated polypeptide, if digested with trypsin, produces polypeptide fragments having masses of 610.29 Da±300 ppm, 628.39 Da±300 ppm, 848.45 Da±300 ppm, 918.45 Da±300 ppm, 1040.60 Da±300 ppm, 1097.62 Da±300 ppm, 1141.60 Da±300 ppm, 1153.63 Da±300 ppm, 1162.50 Da±300 ppm, 1218.66 Da±300 ppm, 1309.63 Da±300 ppm, 1335.71 Da±300 ppm, 1341.66 Da±300 ppm, 1364.60 Da±300 ppm, 1405.76 Da±300 ppm, 1460.70 Da±300 ppm, 1528.70 Da±300 ppm, 1564.76 Da±300 ppm, 1564.76 Da±300 ppm, 1735.86 Da±300 ppm, 1750.86 Da±300 ppm, 1754.83 Da±300 ppm, 1845.91 Da±300 ppm, 1880.96 Da±300 ppm, 1911.98 Da±300 ppm, 1954.02 Da±300 ppm, 2030.93 Da±300 ppm, 2261.06 Da±300 ppm, 2397.12 Da±300 ppm, 2416.14 Da±300 ppm, 2701.36 Da±300 ppm, 2909.36 Da±300 ppm, and 2943.50 Da±300 ppm; anda fifth polypeptide having a molecular weight of about 78 kDa as measured following electrophoresis on an SDS-polyacrylamide gel, wherein the fifth isolated iron-regulated polypeptide, if digested with trypsin, produces polypeptide fragments having masses of 605.33 Da±300 ppm, 614.38 Da±300 ppm, 616.37 Da±300 ppm, 808.41 Da±300 ppm, 836.42 Da±300 ppm, 989.50 Da±300 ppm, 1060.52 Da±300 ppm, 1063.48 Da±300 ppm, 1140.66 Da±300 ppm, 1158.55 Da±300 ppm, 1177.52 Da±300 ppm, 1210.55 Da±300 ppm, 1314.62 Da±300 ppm, 1329.77 Da±300 ppm, 1345.55 Da±300 ppm, 1493.80 Da±300 ppm, 1526.73 Da±300 ppm, 1570.82 Da±300 ppm, 1649.90 Da±300 ppm, 1654.83 Da±300 ppm, 1740.90 Da±300 ppm, 1744.69 Da±300 ppm, 1750.84 Da±300 ppm, 1792.88 Da±300 ppm, 1814.85 Da±300 ppm, 1906.92 Da±300 ppm, 1952.94 Da±300 ppm, 2242.03 Da±300 ppm, 2538.26 Da±300 ppm, and 2710.17 Da±300 ppm. 2. The method of claim 1 wherein the animal is avian, bovine, caprine, ovine, porcine, bisontine, cervine, equine, a companion animal, or human. 3. The method of claim 2 wherein the avian animal is a chicken or turkey. 4. The method of claim 1 further comprising one or more additional administrations of the composition to the animal. 5. The method of claim 1 wherein the parenteral administration comprises subcutaneous administration. 6. A method of decreasing mortality due to infection by a Salmonella spp. in an animal, the method comprising parenterally administering an effective amount of a composition to the animal, wherein the composition comprises: a first isolated iron-regulated polypeptide from Salmonella enterica serovar Enteritidis having a molecular weight of about 92 kDa as measured following electrophoresis on an SDS-polyacrylamide gel, wherein the first isolated iron-regulated polypeptide, if digested with trypsin, produces polypeptide fragments having masses of 728.43 Da±300 parts per million (ppm), 815.38 Da±300 ppm, 888.41 Da±300 ppm, 957.50 Da±300 ppm, 972.50 Da±300 ppm, 986.54 Da±300 ppm, 998.45 Da±300 ppm, 1008.47 Da±300 ppm, 1047.53 Da±300 ppm, 1076.59 Da±300 ppm, 1113.56 Da±300 ppm, 1180.59 Da±300 ppm, 1219.61 Da±300 ppm, 1276.60 Da±300 ppm, 1282.74 Da±300 ppm, 1338.66 Da±300 ppm, 1384.65 Da±300 ppm, 1401.71 Da±300 ppm, 1402.67 Da±300 ppm, 1470.69 Da±300 ppm, 1519.80 Da±300 ppm, 1527.72 Da±300 ppm, 1648.75 Da±300 ppm, 1691.87 Da±300 ppm, 1712.86 Da±300 ppm, 1732.81 Da±300 ppm, 1758.82 Da±300 ppm, 1786.87 Da±300 ppm, 1894.97 Da±300 ppm, 1953.86 Da±300 ppm, 2159.05 Da±300 ppm, 2254.95 Da±300 ppm, 2284.27 Da±300 ppm, 2793.46 Da±300 ppm, and 2881.34 Da±300 ppm;a second isolated iron-regulated polypeptide from Salmonella enterica serovar Enteritidis having a molecular weight of about 91 kDa as measured following electrophoresis on an SDS-polyacrylamide gel, wherein the second isolated iron-regulated polypeptide, if digested with trypsin, produces polypeptide fragments having masses of 904.51 Da±300 ppm, 924.43 Da±300 ppm, 945.53 Da±300 ppm, 1004.49 Da±300 ppm, 1050.50 Da±300 ppm, 1075.60 Da±300 ppm, 1109.55 Da±300 ppm, 1199.63 Da±300 ppm, 1276.56 Da±300 ppm, 1294.58 Da±300 ppm, 1307.68 Da±300 ppm, 1343.65 Da±300 ppm, 1375.72 Da±300 ppm, 1417.75 Da±300 ppm, 1450.68 Da±300 ppm, 1509.63 Da±300 ppm, 1510.72 Da±300 ppm, 1601.89 Da±300 ppm, 1618.81 Da±300 ppm, 1624.79 Da±300 ppm, 1668.72 Da±300 ppm, 1766.91 Da±300 ppm, 1792.85 Da±300 ppm, 1808.87 Da±300 ppm, 1832.89 Da±300 ppm, 2013.02 Da±300 ppm, 2088.13 Da±300 ppm, 2269.01 Da±300 ppm, 2298.03 Da±300 ppm, 2453.09 Da±300 ppm, 2554.16 Da±300 ppm, and 2572.20 Da±300 ppm;a third isolated iron-regulated polypeptide from Salmonella enterica serovar Enteritidis having a molecular weight of about 86 kDa as measured following electrophoresis on an SDS-polyacrylamide gel, wherein the third isolated iron-regulated polypeptide, if digested with trypsin, produces polypeptide fragments having masses of 643.37 Da±300 ppm, 872.46 Da±300 ppm, 950.49 Da±300 ppm, 990.55 Da±300 ppm, 1082.61 Da±300 ppm, 1084.57 Da±300 ppm, 1095.49 Da±300 ppm, 1151.68 Da±300 ppm, 1181.55 Da±300 ppm, 1207.58 Da±300 ppm, 1324.75 Da±300 ppm, 1365.74 Da±300 ppm, 1377.66 Da±300 ppm, 1411.78 Da±300 ppm, 1432.77 Da±300 ppm, 1436.74 Da±300 ppm, 1499.71 Da±300 ppm, 1560.86 Da±300 ppm, 1584.74 Da±300 ppm, 1618.77 Da±300 ppm, 1633.84 Da±300 ppm, 1727.83 Da±300 ppm, 1870.95 Da±300 ppm, 1903.94 Da±300 ppm, 1974.95 Da±300 ppm, 1980.96 Da±300 ppm, 1997.06 Da±300 ppm, 2078.00 Da±300 ppm, 2192.94 Da±300 ppm, 2233.14 Da±300 ppm, 2371.13 Da±300 ppm, 2531.24 Da±300 ppm, 2622.42 Da±300 ppm, 2632.20 Da±300 ppm, 3098.47 Da±300 ppm, 3211.45 Da±300 ppm, and 3473.51 Da±300 ppm;a fourth isolated iron-regulated polypeptide from Salmonella enterica serovar Enteritidis having a molecular weight of about 83 kDa as measured following electrophoresis on an SDS-polyacrylamide gel, wherein the fourth isolated iron-regulated polypeptide, if digested with trypsin, produces polypeptide fragments having masses of 610.29 Da±300 ppm, 628.39 Da±300 ppm, 848.45 Da±300 ppm, 918.45 Da±300 ppm, 1040.60 Da±300 ppm, 1097.62 Da±300 ppm, 1141.60 Da±300 ppm, 1153.63 Da±300 ppm, 1162.50 Da±300 ppm, 1218.66 Da±300 ppm, 1309.63 Da±300 ppm, 1335.71 Da±300 ppm, 1341.66 Da±300 ppm, 1364.60 Da±300 ppm, 1405.76 Da±300 ppm, 1460.70 Da±300 ppm, 1528.70 Da±300 ppm, 1564.76 Da±300 ppm, 1564.76 Da±300 ppm, 1735.86 Da±300 ppm, 1750.86 Da±300 ppm, 1754.83 Da±300 ppm, 1845.91 Da±300 ppm, 1880.96 Da±300 ppm, 1911.98 Da±300 ppm, 1954.02 Da±300 ppm, 2030.93 Da±300 ppm, 2261.06 Da±300 ppm, 2397.12 Da±300 ppm, 2416.14 Da±300 ppm, 2701.36 Da±300 ppm, 2909.36 Da±300 ppm, and 2943.50 Da±300 ppm; anda fifth polypeptide having a molecular weight of about 78 kDa as measured following electrophoresis on an SDS-polyacrylamide gel, wherein the fifth isolated iron-regulated polypeptide, if digested with trypsin, produces polypeptide fragments having masses of 605.33 Da±300 ppm, 614.38 Da±300 ppm, 616.37 Da±300 ppm, 808.41 Da±300 ppm, 836.42 Da±300 ppm, 989.50 Da±300 ppm, 1060.52 Da±300 ppm, 1063.48 Da±300 ppm, 1140.66 Da±300 ppm, 1158.55 Da±300 ppm, 1177.52 Da±300 ppm, 1210.55 Da±300 ppm, 1314.62 Da±300 ppm, 1329.77 Da±300 ppm, 1345.55 Da±300 ppm, 1493.80 Da±300 ppm, 1526.73 Da±300 ppm, 1570.82 Da±300 ppm, 1649.90 Da±300 ppm, 1654.83 Da±300 ppm, 1740.90 Da±300 ppm, 1744.69 Da±300 ppm, 1750.84 Da±300 ppm, 1792.88 Da±300 ppm, 1814.85 Da±300 ppm, 1906.92 Da±300 ppm, 1952.94 Da±300 ppm, 2242.03 Da±300 ppm, 2538.26 Da±300 ppm, and 2710.17 Da±300 ppm. 7. The method of claim 6 wherein the animal is avian, bovine, caprine, ovine, porcine, bisontine, cervine, equine, a companion animal, or human. 8. The method of claim 7 wherein the avian animal is a chicken or turkey. 9. The method of claim 6 further comprising one or more additional administrations of the composition to the animal. 10. The method of claim 6 wherein the parenteral administration comprises subcutaneous administration.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (54)
Daryll A. Emery ; Darren E. Straub ; Richard Huisinga ; Beth A. Carlson, Active immunization using a siderophore receptor protein.
Mill Patrick James (Beaconfield EN) Cresswell Michael Alan (High Wycombe EN) Feinberg Joseph George (London EN), Conjugates of acid polysaccharides and complex organic substances.
Potter Andrew A. (Saskatoon CAX) Harland Richard J. (Saskatoon CAX), Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins.
Schryvers Anthony B. (Calgary CAX), Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of va.
Blake Milan S. (New York NY) Tai Joseph Y. (Fort Washington PA) Qi Huilin L. (New York NY) Liang Shu-Mei (Bethesda MD) Hronowski Lucjan J. J. (Laurel MD) Pullen Jeffrey K. (Columbia MD), Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Ne.
Emery Daryll A. (Willmar MN) Straub Darren E. (Willmar MN) Huisinga Richard (Willmar MN), Method of priming an immune response in a one-day old animal.
Emery,Daryll A.; Straub,Darren E.; Zammert,Donavan E.; Kallevig,Gayla K., Methods for making compositions including gram negative microbial polypeptides.
Cochrum Kent C. (Davis CA) Dorian Randel E. (Orinda CA) Jemtrud Susan A. (San Francisco CA), Multiple layer alginate coatings of biological tissue for transplantation.
Emery, Daryll A.; Straub, Darren E.; Wonderling, Laura; Herron Olson, Lisa L., Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use.
Emery, Daryll A.; Straub, Darren E.; Wonderling, Laura; Herron Olson, Lisa L., Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use.
Emery, Daryll A.; Straub, Darren E.; Wonderling, Laura; Herron Olson, Lisa L., Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use.
Emery, Daryll A.; Straub, Darren E.; Wonderling, Laura; Herron Olson, Lisa L., Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use.
Emery, Daryll A.; Straub, Darren E.; Wonderling, Laura; Herron Olson, Lisa L., Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use.
Tam, Patricia E.; Harris, Michael Nathan; Tripp, Timothy James; Lobo, Sandra, Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.